For ELISA, 96-well microtiter plates (Costar 3590, Corning, NY, USA) were coated with one of the following recombinant influenza HA proteins: A/Puerto Rico/8/1934(H1N1) (cat. no. 11684-V08H, Sino Biological), A/Viet Nam/1194/2004(H5N1) (cat. no. 11062-V08H1, Sino Biological), or A/Hong Kong/1073/99(H9N2) (cat. no. 11229-V08H, Sino Biological) (0.5 μg/mL). Plates were blocked by 1% BSA in PBS at room temperature for 1 h. Serially diluted sera from individual mice were then incubated at 4°C for 16 to 18 h. Murine IgG was detected by incubation for 1 h with either horseradish peroxidase (HRP)-conjugated anti-mouse IgG (Fc specific) (1:5,000; cat. no. A2554, Merck, New Jersey, USA), biotinylated anti-mouse IgG1[a] (1:500; cat. no. 553500, BD Biosciences, New Jersey, USA), or biotinylated anti-mouse IgG2a[a] (1:500; cat. no. 553504, BD Biosciences). For biotinylated antibodies, a secondary incubation with HRP-conjugated streptavidin (1:5,000; cat.no. 7105-05, SouthernBiotech, Alabama, USA) at room temperature for 30 min was performed. The plates were developed by addition of 3,3′,5,5′-tetramethylbenzidine (TMB) solution (cat. no. CL07-1000ML, Merck), and the reaction was stopped after 10 min by addition of 1 M H2SO4. Absorbance at 450 nm was read using a Wallac EnVision 2104 Multilabel Reader (PerkinElmer, Massachusetts, USA).
Influenza Antibody Detection ELISA
For ELISA, 96-well microtiter plates (Costar 3590, Corning, NY, USA) were coated with one of the following recombinant influenza HA proteins: A/Puerto Rico/8/1934(H1N1) (cat. no. 11684-V08H, Sino Biological), A/Viet Nam/1194/2004(H5N1) (cat. no. 11062-V08H1, Sino Biological), or A/Hong Kong/1073/99(H9N2) (cat. no. 11229-V08H, Sino Biological) (0.5 μg/mL). Plates were blocked by 1% BSA in PBS at room temperature for 1 h. Serially diluted sera from individual mice were then incubated at 4°C for 16 to 18 h. Murine IgG was detected by incubation for 1 h with either horseradish peroxidase (HRP)-conjugated anti-mouse IgG (Fc specific) (1:5,000; cat. no. A2554, Merck, New Jersey, USA), biotinylated anti-mouse IgG1[a] (1:500; cat. no. 553500, BD Biosciences, New Jersey, USA), or biotinylated anti-mouse IgG2a[a] (1:500; cat. no. 553504, BD Biosciences). For biotinylated antibodies, a secondary incubation with HRP-conjugated streptavidin (1:5,000; cat.no. 7105-05, SouthernBiotech, Alabama, USA) at room temperature for 30 min was performed. The plates were developed by addition of 3,3′,5,5′-tetramethylbenzidine (TMB) solution (cat. no. CL07-1000ML, Merck), and the reaction was stopped after 10 min by addition of 1 M H2SO4. Absorbance at 450 nm was read using a Wallac EnVision 2104 Multilabel Reader (PerkinElmer, Massachusetts, USA).
Corresponding Organization : Oslo University Hospital
Variable analysis
- Type of recombinant influenza HA protein used to coat the 96-well microtiter plates: A/Puerto Rico/8/1934(H1N1), A/Viet Nam/1194/2004(H5N1), or A/Hong Kong/1073/99(H9N2)
- Binding of murine IgG antibodies to the recombinant influenza HA proteins, as measured by absorbance at 450 nm
- Concentration of recombinant influenza HA proteins used to coat the 96-well microtiter plates (0.5 μg/mL)
- Blocking of the plates with 1% BSA in PBS
- Incubation time of serially diluted sera (16 to 18 h at 4°C)
- Detection method for murine IgG (HRP-conjugated anti-mouse IgG, biotinylated anti-mouse IgG1, or biotinylated anti-mouse IgG2a)
- Incubation time for detection antibodies (1 h for HRP-conjugated, 30 min for HRP-conjugated streptavidin)
- Development time of TMB solution (10 min)
- Stopping the reaction with 1 M H2SO4
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!